Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
GlycoMimetics (NASDAQ: GLYC) shares nearly tripled, zooming 188% from 17 cents to 49 cents Tuesday after the company announced it had agreed to be acquired by privately held Crescent Biopharma for an undisclosed amount
Wansleeben C, Feitsma H, Montcouquiol M, Kroon C, Cuppen E, Meijlink F
Additionally, some patients may benefit from switching to generic liraglutide or other drugs in the same class that are currently available as generics
Blissenbach understand your unique situation and create a personalized plan
Nrf2 signaling pathway: focus on oxidative stress in spinal cord injury
US$ 26.28
US$ 29.89
US$ 27.81
